These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 25036022)

  • 21. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
    Santra A; Kumar R; Sharma P; Bal C; Kumar A; Julka PK; Malhotra A
    Eur J Radiol; 2012 Mar; 81(3):508-13. PubMed ID: 21353420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Utility of 11C-methionine PET/CT in neuro-oncology].
    Casas Parera I; Igirio Gamero JL; Blumenkrantz Y; Bruno G; Báez A; Tafur Canabal JG; Báez M; Kuchkaryan V
    Medicina (B Aires); 2013; 73(3):201-6. PubMed ID: 23732194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sequential analysis of the integrated images of PET, CT and MR in malignant brain tumors before and after radiotherapy].
    Suzuki A; Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1996 May; 48(5):449-57. PubMed ID: 8672304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors.
    Schinkelshoek M; Lopci E; Clerici E; Alongi F; Mancosu P; Rodari M; Navarria P; van der Hiel B; Scorsetti M; Chiti A
    Tumori; 2014; 100(6):636-44. PubMed ID: 25688497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the Diagnostic Efficacy of
    Kumar P; Kumar A; Nagaraj C; Sadashiva N; Saini J; Mangalore S; Rajan A; Sitani K; Beniwal M; Santosh V; Basavaraja H; Hazari PP; Mishra AK
    Cancer Biother Radiopharm; 2024 Jun; 39(5):349-357. PubMed ID: 38324045
    [No Abstract]   [Full Text] [Related]  

  • 29. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.
    Ceyssens S; Van Laere K; de Groot T; Goffin J; Bormans G; Mortelmans L
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1432-7. PubMed ID: 16908552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment.
    Minamimoto R; Saginoya T; Kondo C; Tomura N; Ito K; Matsuo Y; Matsunaga S; Shuto T; Akabane A; Miyata Y; Sakai S; Kubota K
    PLoS One; 2015; 10(7):e0132515. PubMed ID: 26167681
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Deuschl C; Kirchner J; Poeppel TD; Schaarschmidt B; Kebir S; El Hindy N; Hense J; Quick HH; Glas M; Herrmann K; Umutlu L; Moenninghoff C; Radbruch A; Forsting M; Schlamann M
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):593-601. PubMed ID: 29282517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
    Khangembam BC; Sharma P; Karunanithi S; Singhal A; Das CJ; Kumar P; Julka PK; Bandopadhyaya GP; Kumar R; Malhotra A; Bal C
    Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.
    Pöpperl G; Götz C; Rachinger W; Gildehaus FJ; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1464-70. PubMed ID: 15248032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
    Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of post-treatment metabolic tumor volume from
    Jung TY; Min JJ; Bom HS; Jung S; Kim IY; Lim SH; Kim DY; Kwon SY
    Neurosurg Rev; 2017 Apr; 40(2):223-229. PubMed ID: 27282449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.
    Berntsson SG; Falk A; Savitcheva I; Godau A; Zetterling M; Hesselager G; Alafuzoff I; Larsson EM; Smits A
    J Neurooncol; 2013 Sep; 114(2):241-9. PubMed ID: 23771511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
    Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
    Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.
    Riva M; Lopci E; Castellano A; Olivari L; Gallucci M; Pessina F; Fernandes B; Simonelli M; Navarria P; Grimaldi M; Rudà R; Castello A; Rossi M; Alfiero T; Soffietti R; Chiti A; Bello L
    World Neurosurg; 2019 Jun; 126():e270-e280. PubMed ID: 30797926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid study of cerebral gliomas using positron emission tomography--analysis of (11C-methyl)-L-methionine uptake index.
    Mineura K; Sasajima T; Suda Y; Kowada M; Shishido F; Uemura K
    Neurol Med Chir (Tokyo); 1990 Dec; 30(13):997-1002. PubMed ID: 1714054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.